Kenneth A. Berlin

Kenneth A. Berlin is the current President & CEO at Advaxis. Kenneth has held this position since April of 2018. Prior to Advaxis, Kenneth was the President & CEO of Rosetta Genomics from November 2009 to April 2018. Before Rosetta Genomics, Kenneth was the Worldwide General Manager at Veridex, LLC from January 2007 to December 2009. Veridex, LLC is a Johnson & Johnson company. From January 2004 to December 2007, Kenneth was the VP of Franchise Development at Ortho Clinical Diagnostics, also a J&J company. Kenneth's experience in the medical field, specifically in diagnostics, has led him to their success as the Advaxis President & CEO.

Kenneth A. Berlin received their AB in Political Economy from Princeton University and their JD in Law from the University of California, Los Angeles - School of Law.